Insights

Evidence for Sharper Leadership Decisions

Operating data, field signal, and research from LiquidSMARTS℠. What we measure in our own practice, what our newsletter tells commercial leaders, and what the field is telling us this week.

The Boomerang Newsletter

What’s Already In The Room

Field signal, mechanic, and move, published on LinkedIn and archived here for MedTech commercial leaders who read after the fact.

MedTech Commercial Index

The market, read for commercial signal

Three equal-weighted bands of public MedTech companies, plus the launches, sales-force moves, reimbursement calls, and contracts behind them. Updated every trading day after the close.

Composite

106.53

-1.83% day · +6.5% YTD

Core

94.84

-1.37% day · -5.2% YTD

Commercial Watch

111.71

-1.30% day · +11.7% YTD

Broad Market

106.36

-1.83% day · +6.4% YTD

Open the index and full signal feed

Recent LinkedIn Analysis

Daily Field Signal

Ten recent posts from the daily MedTech commercial intelligence feed. Read the full analysis on LinkedIn.

A focused first conversation

Bring us one decision your leaders handle unevenly.

A forecast call, a stalled deal, a coaching conversation, or an operating review. We will look at where the judgment slipped, which gain would make it hold, and how you would see the change in the operation.

The decision

Which call does the leader get right some weeks and wrong in others, and what does the miss cost?

The gain

What should the leader see more clearly, do more reliably, or be trusted to own? What access or authority would that take?

The evidence

How will we recognize sound judgment on the next decision, and which operating measure will show it?

We take on work when our priorities align and the project has discernible value. Together, we agree the scope, the evidence of progress, the time commitment, and the fee.

Bring us one decision